{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:02:18Z","timestamp":1792800138787,"version":"4.5.0"},"reference-count":37,"publisher":"European Respiratory Society (ERS)","issue":"4","license":[{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"investigator-initiated grant from GlaxoSmithKline to McMaster University","id":[{"id":"https:\/\/ror.org\/02fa3aq29","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2025,10,22]]},"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Patients presenting with chronic cough often have eosinophilic airways disease that remains refractory despite inhaled or oral corticosteroids. Studies in asthma patients have shown that eosinophils co-localise with airway sensory nerves, and after allergen challenge, are associated with neuronal sensitivity. We evaluated whether mepolizumab, a monoclonal antibody targeting interleukin-5, reduces cough in patients with eosinophilic airways disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a single-centre, randomised, double-blind, parallel-group, placebo-controlled trial of 30 patients with refractory chronic cough and eosinophilic airways disease (sputum eosinophils \u22652%). Patients underwent 1:1 randomisation to receive subcutaneous mepolizumab (100\u2005mg) or placebo every 4\u2005weeks for 12\u2005weeks. Change from baseline in 24-h cough frequency at 14\u2005weeks represented the primary end-point.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements and main results<\/jats:title>\n                    <jats:p>\n                      Compared to placebo, mepolizumab did not lead to improvements in 24-h cough frequency at 14\u2005weeks (percentage change relative to placebo +18.0%, 95% CI \u221246.4\u2013160.1%; p=0.99). We found no between-group differences in awake cough frequency, sleep cough frequency, cough severity on the 100-mm visual analogue scale, and quality of life on the Leicester Cough Questionnaire. Mepolizumab significantly reduced blood eosinophils compared to placebo at week 14 (mean difference \u2212237.7\u2005cells\u00b7\u00b5L\n                      <jats:sup>\u22121<\/jats:sup>\n                      , 95% CI \u2212328.3\u2013\u2212147.1 cells\u00b7\u00b5L\n                      <jats:sup>\u22121<\/jats:sup>\n                      ; p&lt;0.0001) and had a significant overall effect in reducing sputum eosinophils over the study (p=0.045). No major adverse events occurred.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In patients with refractory chronic cough and persistent eosinophilia despite inhaled corticosteroid therapy, mepolizumab did not improve cough despite reducing blood and sputum eosinophils. Targeting eosinophils might not impact cough in these patients, and their cough is probably driven by alternative mechanisms.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1183\/13993003.01573-2025","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T18:00:27Z","timestamp":1762452027000},"page":"2501573","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Mepolizumab for the treatment of refractory chronic cough in patients with eosinophilic airways disease (MUCOSA): a randomised, double-blind, parallel-group, placebo-controlled trial"],"prefix":"10.1183","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7045-6092","authenticated-orcid":false,"given":"Nermin","family":"Diab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danica","family":"Brister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Kum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafaa","family":"Wahab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1461-4367","authenticated-orcid":false,"given":"Wafa","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue","family":"Beaudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catie","family":"Obminski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Wattie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley","family":"Wiltshire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Howie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kieran","family":"Killian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0413-8085","authenticated-orcid":false,"given":"Kimberley","family":"Holt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0968-6304","authenticated-orcid":false,"given":"Roma","family":"Sehmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6187-2385","authenticated-orcid":false,"given":"Gail M.","family":"Gauvreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8837-4928","authenticated-orcid":false,"given":"Jaclyn A.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0979-281X","authenticated-orcid":false,"given":"Paul M.","family":"O'Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4206-6000","authenticated-orcid":false,"given":"Imran","family":"Satia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2025,11,6]]},"reference":[{"key":"2026040201301884000_67.4.2501573.1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00218714"},{"key":"2026040201301884000_67.4.2501573.2","doi-asserted-by":"publisher","DOI":"10.1007\/s00408-022-00575-6"},{"key":"2026040201301884000_67.4.2501573.3","unstructured":"Global Initiative for Asthma (GINA) . Global Strategy for Asthma Management and Prevention. 2024. Available from: http:\/\/ginasthma.org\/"},{"key":"2026040201301884000_67.4.2501573.4","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/S0140-6736(89)92801-8","article-title":"Chronic cough: eosinophilic bronchitis without asthma","volume":"1","author":"Gibson","year":"1989","journal-title":"Lancet"},{"key":"2026040201301884000_67.4.2501573.5","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/141.3.640"},{"key":"2026040201301884000_67.4.2501573.6","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.160.2.9810100"},{"key":"2026040201301884000_67.4.2501573.7","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1378\/chest.12-0441","article-title":"A prospective, multicenter survey on causes of chronic cough in China","volume":"143","author":"Lai","year":"2013","journal-title":"Chest"},{"key":"2026040201301884000_67.4.2501573.8","doi-asserted-by":"publisher","DOI":"10.1053\/rmed.2003.1503"},{"key":"2026040201301884000_67.4.2501573.9","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01136-2019"},{"key":"2026040201301884000_67.4.2501573.10","doi-asserted-by":"publisher","DOI":"10.1378\/chest.15-1496"},{"key":"2026040201301884000_67.4.2501573.11","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.chest.2019.12.021","article-title":"Managing chronic cough due to asthma and NAEB in adults and adolescents: CHEST guideline and expert panel report","volume":"158","author":"C\u00f4t\u00e9","year":"2020","journal-title":"Chest"},{"key":"2026040201301884000_67.4.2501573.12","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009305.pub2"},{"key":"2026040201301884000_67.4.2501573.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2004.03.019"},{"key":"2026040201301884000_67.4.2501573.14","doi-asserted-by":"publisher","DOI":"10.1016\/S1081-1206(10)60623-0"},{"key":"2026040201301884000_67.4.2501573.15","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.congress-2024.PA324"},{"key":"2026040201301884000_67.4.2501573.16","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00039.2015"},{"key":"2026040201301884000_67.4.2501573.17","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.jaci.2018.11.050","article-title":"Allergen challenge increases capsaicin-evoked cough responses in patients with allergic asthma","volume":"144","author":"Satia","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"2026040201301884000_67.4.2501573.18","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aar8477"},{"key":"2026040201301884000_67.4.2501573.19","doi-asserted-by":"crossref","first-page":"A2102","DOI":"10.1164\/ajrccm.2025.211.Abstracts.A2102","article-title":"Mepolizumab for the treatment of refractory chronic cough with eosinophilic airways disease (MUCOSA): a randomized, double-blind, placebo-controlled trial","volume":"211","author":"Diab","year":"2025","journal-title":"Am J Respir Crit Care Med"},{"key":"2026040201301884000_67.4.2501573.20","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.04271-2020"},{"key":"2026040201301884000_67.4.2501573.21","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.58.4.339"},{"key":"2026040201301884000_67.4.2501573.22","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)02348-5"},{"key":"2026040201301884000_67.4.2501573.23","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1164\/rccm.202501-0093RL","article-title":"Camlipixant in refractory chronic cough: a phase 2a, randomized, controlled trial (RELIEF)","volume":"211","author":"Smith","year":"2025","journal-title":"Am J Respir Crit Care Med"},{"key":"2026040201301884000_67.4.2501573.24","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1164\/rccm.202409-1752OC","article-title":"Camlipixant in refractory chronic cough: a phase 2b, randomized, placebo-controlled trial (SOOTHE)","volume":"211","author":"Smith","year":"2025","journal-title":"Am J Respir Crit Care Med"},{"key":"2026040201301884000_67.4.2501573.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2019.08.001"},{"key":"2026040201301884000_67.4.2501573.26","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S2213-2600(23)00187-X","article-title":"Cough and cough hypersensitivity as treatable traits of asthma","volume":"11","author":"Lai","year":"2023","journal-title":"Lancet Respir Med"},{"key":"2026040201301884000_67.4.2501573.27","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2001.112940"},{"key":"2026040201301884000_67.4.2501573.28","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.R113.546218"},{"key":"2026040201301884000_67.4.2501573.29","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2313318"},{"key":"2026040201301884000_67.4.2501573.30","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41572-022-00370-w","article-title":"Cough hypersensitivity and chronic cough","volume":"8","author":"Chung","year":"2022","journal-title":"Nat Rev Dis Primers"},{"key":"2026040201301884000_67.4.2501573.31","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01387-2020"},{"key":"2026040201301884000_67.4.2501573.32","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02203-2018"},{"key":"2026040201301884000_67.4.2501573.33","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.anai.2023.04.022","article-title":"Targeting the interleukin-5 pathway improves cough hypersensitivity in patients with severe uncontrolled asthma","volume":"131","author":"Ito","year":"2023","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2026040201301884000_67.4.2501573.34","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s00408-020-00391-w","article-title":"Objective assessment of cough: an early marker of response to biological therapies in asthma?","volume":"198","author":"Faruqi","year":"2020","journal-title":"Lung"},{"key":"2026040201301884000_67.4.2501573.35","doi-asserted-by":"crossref","first-page":"A1392","DOI":"10.1164\/ajrccm.2025.211.Abstracts.A1392","article-title":"Efficacy of benralizumab in reducing cough frequency and improving health-related quality of life in patients with severe eosinophilic asthma in Asia: a post-hoc analysis of the phase 3 miracle study","volume":"211","author":"Lai","year":"2025","journal-title":"Am J Respir Crit Care Med"},{"key":"2026040201301884000_67.4.2501573.36","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S2213-2600(25)00018-9","article-title":"Placebo responses in clinical trials of refractory chronic cough: mechanisms, challenges, and mitigation strategies","volume":"13","author":"Kum","year":"2025","journal-title":"Lancet Respir Med"},{"key":"2026040201301884000_67.4.2501573.37","doi-asserted-by":"publisher","DOI":"10.1378\/chest.1117302"}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/13993003.01573-2025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T08:30:28Z","timestamp":1775118628000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/13993003.01573-2025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,6]]},"references-count":37,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4,2]]},"published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10.1183\/13993003.01573-2025"],"URL":"https:\/\/doi.org\/10.1183\/13993003.01573-2025","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"value":"0903-1936","type":"print"},{"value":"1399-3003","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,6]]}}}